1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. Key Offerings
1.2. Market Segmentation
1.3. Research Methodology
1.3.1. Phase I - Secondary Research
1.3.2. Phase II - Primary Research
1.3.3. Phase III - Expert Panel Review
1.3.4. Assumptions
1.3.5. Approach Adopted
2. Executive Summary
2.1. Market Snapshot: Global Intravitreal Injectables Market
2.3. Global Intravitreal Injectables Market, By Indication, 2025 (US$ Million)
2.4. Global Intravitreal Injectables Market, By Drug Class, 2025 (US$ Million)
2.5. Global Intravitreal Injectables Market, By Geography, 2025 (US$ Million)
2.6. Attractive Investment Proposition by Geography, 2025
3. Intravitreal Injectables Market: Competitive Analysis
3.1. Market Positioning of Key Intravitreal Injectables Market Vendors
3.2. Strategies Adopted by Intravitreal Injectables Market Vendors
4. Intravitreal Injectables Market: Macro Analysis & Market Dynamics
4.1. Introduction
4.2. Global Intravitreal Injectables Market Value, 2024 - 2034, (US$ Million)
4.3. Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Key Challenges
4.3.4. Key Opportunities
4.4. Impact Analysis of Drivers and Restraints
4.5. Porter's Five Force Model
4.5.1. Supplier Power
4.5.2. Buyer Power
4.5.3. Threat Of Substitutes
4.5.4. Threat Of New Entrants
4.5.5. Competitive Rivalry
4.6. PESTEL Analysis
4.6.1. Political Landscape
4.6.2. Economic Landscape
4.6.3. Social Landscape
4.6.4. Technology Landscape
4.6.5. Environmental Landscape
4.6.6. Legal Landscape
5. Intravitreal Injectables Market: By Indication, 2024-2034, USD (Million)
5.1. Market Overview
5.2. Growth & Revenue Analysis: 2025 Versus 2034
5.3. Market Segmentation
5.3.1. Macular Degeneration
5.3.2. Diabetic Retinopathy
5.3.3. Retinal Vein Occlusions
5.3.4. Endophthalmitis
5.3.5. Others
6. Intravitreal Injectables Market: By Drug Class, 2024-2034, USD (Million)
6.1. Market Overview
6.2. Growth & Revenue Analysis: 2025 Versus 2034
6.3. Market Segmentation
6.3.1. Anti-VEGF
6.3.2. Corticosteroids
6.3.3. Antibiotics
6.3.4. Antivirals
6.3.5. Antifungals
7. North America Intravitreal Injectables Market, 2024-2034, USD (Million)
7.1. Market Overview
7.2. Intravitreal Injectables Market: By Indication, 2024-2034, USD (Million)
7.3. Intravitreal Injectables Market: By Drug Class, 2024-2034, USD (Million)
7.4. Intravitreal Injectables Market: By Region, 2024-2034, USD (Million)
7.4.1.North America
7.4.1.1. U.S.
7.4.1.1.1. Intravitreal Injectables Market: By Indication, 2024-2034, USD (Million)
7.4.1.1.2. Intravitreal Injectables Market: By Drug Class, 2024-2034, USD (Million)
7.4.1.2. Canada
7.4.1.2.1. Intravitreal Injectables Market: By Indication, 2024-2034, USD (Million)
7.4.1.2.2. Intravitreal Injectables Market: By Drug Class, 2024-2034, USD (Million)
7.4.1.3. Rest of North America
7.4.1.3.1. Intravitreal Injectables Market: By Indication, 2024-2034, USD (Million)
7.4.1.3.2. Intravitreal Injectables Market: By Drug Class, 2024-2034, USD (Million)
8. UK and European Union Intravitreal Injectables Market, 2024-2034, USD (Million)
8.1. Market Overview
8.2. Intravitreal Injectables Market: By Indication, 2024-2034, USD (Million)
8.3. Intravitreal Injectables Market: By Drug Class, 2024-2034, USD (Million)
8.4. Intravitreal Injectables Market: By Region, 2024-2034, USD (Million)
8.4.1.UK and European Union
8.4.1.1. UK
8.4.1.1.1. Intravitreal Injectables Market: By Indication, 2024-2034, USD (Million)
8.4.1.1.2. Intravitreal Injectables Market: By Drug Class, 2024-2034, USD (Million)
8.4.1.2. Germany
8.4.1.2.1. Intravitreal Injectables Market: By Indication, 2024-2034, USD (Million)
8.4.1.2.2. Intravitreal Injectables Market: By Drug Class, 2024-2034, USD (Million)
8.4.1.3. Spain
8.4.1.3.1. Intravitreal Injectables Market: By Indication, 2024-2034, USD (Million)
8.4.1.3.2. Intravitreal Injectables Market: By Drug Class, 2024-2034, USD (Million)
8.4.1.4. Italy
8.4.1.4.1. Intravitreal Injectables Market: By Indication, 2024-2034, USD (Million)
8.4.1.4.2. Intravitreal Injectables Market: By Drug Class, 2024-2034, USD (Million)
8.4.1.5. France
8.4.1.5.1. Intravitreal Injectables Market: By Indication, 2024-2034, USD (Million)
8.4.1.5.2. Intravitreal Injectables Market: By Drug Class, 2024-2034, USD (Million)
8.4.1.6. Rest of Europe
8.4.1.6.1. Intravitreal Injectables Market: By Indication, 2024-2034, USD (Million)
8.4.1.6.2. Intravitreal Injectables Market: By Drug Class, 2024-2034, USD (Million)
9. Asia Pacific Intravitreal Injectables Market, 2024-2034, USD (Million)
9.1. Market Overview
9.2. Intravitreal Injectables Market: By Indication, 2024-2034, USD (Million)
9.3. Intravitreal Injectables Market: By Drug Class, 2024-2034, USD (Million)
9.4. Intravitreal Injectables Market: By Region, 2024-2034, USD (Million)
9.4.1.Asia Pacific
9.4.1.1. China
9.4.1.1.1. Intravitreal Injectables Market: By Indication, 2024-2034, USD (Million)
9.4.1.1.2. Intravitreal Injectables Market: By Drug Class, 2024-2034, USD (Million)
9.4.1.2. Japan
9.4.1.2.1. Intravitreal Injectables Market: By Indication, 2024-2034, USD (Million)
9.4.1.2.2. Intravitreal Injectables Market: By Drug Class, 2024-2034, USD (Million)
9.4.1.3. India
9.4.1.3.1. Intravitreal Injectables Market: By Indication, 2024-2034, USD (Million)
9.4.1.3.2. Intravitreal Injectables Market: By Drug Class, 2024-2034, USD (Million)
9.4.1.4. Australia
9.4.1.4.1. Intravitreal Injectables Market: By Indication, 2024-2034, USD (Million)
9.4.1.4.2. Intravitreal Injectables Market: By Drug Class, 2024-2034, USD (Million)
9.4.1.5. South Korea
9.4.1.5.1. Intravitreal Injectables Market: By Indication, 2024-2034, USD (Million)
9.4.1.5.2. Intravitreal Injectables Market: By Drug Class, 2024-2034, USD (Million)
9.4.1.6. Rest of Asia Pacific
9.4.1.6.1. Intravitreal Injectables Market: By Indication, 2024-2034, USD (Million)
9.4.1.6.2. Intravitreal Injectables Market: By Drug Class, 2024-2034, USD (Million)
10. Latin America Intravitreal Injectables Market, 2024-2034, USD (Million)
10.1. Market Overview
10.2. Intravitreal Injectables Market: By Indication, 2024-2034, USD (Million)
10.3. Intravitreal Injectables Market: By Drug Class, 2024-2034, USD (Million)
10.4. Intravitreal Injectables Market: By Region, 2024-2034, USD (Million)
10.4.1.Latin America
10.4.1.1. Brazil
10.4.1.1.1. Intravitreal Injectables Market: By Indication, 2024-2034, USD (Million)
10.4.1.1.2. Intravitreal Injectables Market: By Drug Class, 2024-2034, USD (Million)
10.4.1.2. Mexico
10.4.1.2.1. Intravitreal Injectables Market: By Indication, 2024-2034, USD (Million)
10.4.1.2.2. Intravitreal Injectables Market: By Drug Class, 2024-2034, USD (Million)
10.4.1.3. Rest of Latin America
10.4.1.3.1. Intravitreal Injectables Market: By Indication, 2024-2034, USD (Million)
10.4.1.3.2. Intravitreal Injectables Market: By Drug Class, 2024-2034, USD (Million)
11. Middle East and Africa Intravitreal Injectables Market, 2024-2034, USD (Million)
11.1. Market Overview
11.2. Intravitreal Injectables Market: By Indication, 2024-2034, USD (Million)
11.3. Intravitreal Injectables Market: By Drug Class, 2024-2034, USD (Million)
11.4. Intravitreal Injectables Market: By Region, 2024-2034, USD (Million)
11.4.1.Middle East and Africa
11.4.1.1. GCC
11.4.1.1.1. Intravitreal Injectables Market: By Indication, 2024-2034, USD (Million)
11.4.1.1.2. Intravitreal Injectables Market: By Drug Class, 2024-2034, USD (Million)
11.4.1.2. Africa
11.4.1.2.1. Intravitreal Injectables Market: By Indication, 2024-2034, USD (Million)
11.4.1.2.2. Intravitreal Injectables Market: By Drug Class, 2024-2034, USD (Million)
11.4.1.3. Rest of Middle East and Africa
11.4.1.3.1. Intravitreal Injectables Market: By Indication, 2024-2034, USD (Million)
11.4.1.3.2. Intravitreal Injectables Market: By Drug Class, 2024-2034, USD (Million)
12. Company Profile
12.1. Allergan, Inc. (Company Overview, Financial Performance, Product Portfolio, Strategic Initiatives)
12.2. Alimera Sciences
12.3. Bristol-Myers Squibb Company
12.4. Eyetech, Inc.
12.5. F. Hoffmann-La Roche Ltd
12.6. Genentech, Inc.
12.7. Novartis AG
12.8. Regeneron Pharmaceuticals, Inc.
12.9. ThromboGenics, Inc.
12.10. Valeant Pharmaceuticals International, Inc.
